Redhill Biopharma (RDHL) vs cbdMD (YCBD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Redhill Biopharma is the larger company by market cap ($4.8 million vs $4.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RDHL | YCBD |
|---|---|---|
| Share price | $0.5451 | $0.3857 |
| Market cap | $4.84M | $4.32M |
| 1-day change | -5.62% | -1.93% |
| P/E ratio (TTM) | — | 1.68 |
| Forward P/E | 18.17 | — |
| EPS (TTM) | $0.00 | $0.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.14 | $2.56 |
| 52-week low | $0.435 | $0.38 |
| Distance from 52-week high | -74.53% | -84.93% |
| Analyst consensus | — | none |
| Average volume | 2.05M | 433.66K |
| Shares outstanding | 8.89M | 11.21M |
| Employees | 13 | 42 |
| Sector | Health Care | Consumer Discretionary |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Redhill Biopharma in Health Care and cbdMD in Consumer Discretionary.
About Redhill Biopharma
RDHL stock →RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
About cbdMD
YCBD stock →cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally.
Consumer Discretionary · Package Goods/Cosmetics · 42 employees
RDHL vs YCBD FAQ
Which is bigger, Redhill Biopharma or cbdMD?
Redhill Biopharma (RDHL) is larger, with a market capitalization of $4.84M compared with $4.32M for cbdMD (YCBD).
Are Redhill Biopharma and cbdMD in the same industry?
No. Redhill Biopharma is in the Health Care sector, while cbdMD is in Consumer Discretionary.